UBS Group
ONEM

UBS Group’s 1Life Healthcare ONEM Stock Holding History

UBS Group’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,036,785
Closed -$17.3M – 11380
2022
Q4 		$17.3M Buy
1,036,785
+207,148
+25% +$3.5M 0.01% 1521
2022
Q3 		$14.2M Buy
829,637
+829,037
+138,173% +$13M 0.01% 1512
2022
Q2 		$5K Sell
600
-857
-59% -$7.36K ﹤0.01% 8992
2022
Q1 		$16K Sell
1,457
-14,371
-91% -$161K ﹤0.01% 7785
2021
Q4 		$278K Sell
15,828
-27,159
-63% -$527K ﹤0.01% 5424
2021
Q3 		$870K Buy
42,987
+11,818
+38% +$304K ﹤0.01% 4304
2021
Q2 		$1.03M Sell
31,169
-51,302
-62% -$1.94M ﹤0.01% 4146
2021
Q1 		$3.22M Buy
82,471
+4,306
+6% +$202K ﹤0.01% 3056
2020
Q4 		$3.41M Buy
78,165
+49,145
+169% +$1.68M ﹤0.01% 2862
2020
Q3 		$823K Sell
29,020
-56,394
-66% -$1.78M ﹤0.01% 3780
2020
Q2 		$3.1M Buy
85,414
+70,072
+457% +$1.97M ﹤0.01% 2466
2020
Q1 		$278K Buy
+15,342
New +$336K ﹤0.01% 4457

UBS Group's ONEM Position: Q1 2023 in Review

UBS Group sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 1,036,785 shares — an estimated $17.3M sold.

UBS Group first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $17.3M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • UBS Group reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 1,036,785 1Life Healthcare shares in Q1 2023, an estimated $17.3M.
  • UBS Group first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • UBS Group's 1Life Healthcare position peaked at $17.3M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.